Ultragenyx Pharmaceutical | Eiendeler

Assets Endring Dato
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Insmed USD 1.16B 170.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Kyowa Hakko Kirin JPY 1.07T 39.94B 2024-03
MacroGenics USD 248.28M 50.13M 2024-03
Moderna USD 16.73B 1.7B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Ultragenyx Pharmaceutical Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.